BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2019 7:21:43 AM | Browse: 1304 | Download: 2484
 |
Received |
|
2019-09-03 07:35 |
|
Peer-Review Started |
|
2019-09-03 07:35 |
|
First Decision by Editorial Office Director |
|
2019-09-23 05:27 |
|
Return for Revision |
|
2019-10-15 02:34 |
|
Revised |
|
2019-10-18 16:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-10-25 02:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-10-29 17:43 |
|
Articles in Press |
|
2019-10-29 17:43 |
|
Edit the Manuscript by Language Editor |
|
2019-11-04 00:13 |
|
Typeset the Manuscript |
|
2019-11-21 12:04 |
|
Publish the Manuscript Online |
|
2019-11-26 07:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Retrospective Study |
| Article Title |
End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Fan-Hua Kong, Xiong-Ying Miao, Heng Zou, Li Xiong, Yu Wen, Bo Chen, Xi Liu and Jiang-Jiao Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Hunan Province |
2019JJ50874 |
|
| Corresponding Author |
Jiang-Jiao Zhou, MD, Doctor, Doctor, Department of General Surgery, The Second Xiangya Hospital, Central South University, Renming Road, Changsha 410011, Hunan Province, China. zhoujiangjiao@csu.edu.cn |
| Key Words |
Post-hepatectomy liver failure; Hepatocellular carcinoma; Hepatectomy; Model for end-stage liver disease; Standardized future liver remnant; Hepatitis B virus |
| Core Tip |
Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the second leading cause of death from cancer worldwide. At present, Post-hepatectomy liver failure (PHLF) is still one of the main causes of death for HCC patients undergoing hepatectomy. Although standardized future liver remnant (sFLR) or model for end-stage liver disease (MELD) can predict the occurrence of PHLF to a certain extent, their sensitivity and specificity do not sufficiently meet clinical needs. The combination of sFLR volume with MELD score is a reliable predictor of PHLF. This measurement can effectively guide the early management after hepatectomy, thereby improving the prognosis and reducing the mortality. Also, the model can provide a new strategy for the preoperative evaluation of hepatectomy. |
| Publish Date |
2019-11-26 07:21 |
| Citation |
Kong FH, Miao XY, Zou H, Xiong L, Wen Y, Chen B, Liu X, Zhou JJ. End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma. World J Clin Cases 2019; 7(22): 3734-3741 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i22/3734.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i22.3734 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
